Kumar, Rajesh, Sunil Kumar Singh, Shruti Singh, and Alok Kumar. 2025. “Addressing Cardio-Metabolic Risks in Type 2 Diabetes: Evidence-Based Insights on Efpeglenatide”. International Journal of Basic & Clinical Pharmacology 14 (4):565-82. https://doi.org/10.18203/2319-2003.ijbcp20251843.